Radionuclide imaging helps predict cardiac events in heart patients

03/2/2010 | Modern Medicine

Radionuclide imaging using myocardial iodine-123 meta-iodobenzylguanidine scintigraphy to evaluate how the myocardium is stimulated helps predict cardiac events in patients with heart failure and reduced left ventricular ejection fraction, a study said. The study involved 961 patients with heart failure and 35% or less LVEF.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD